Skip to main content

Harith Rajagopalan, M.D., Ph.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Fractyl Health, Inc. publishes a filing, an earnings call transcript or a press release.

Get GUTS alerts

About Harith Rajagopalan, M.D., Ph.D.

Fractyl Health, Inc. reported in an 8-K filed October 22, 2026 that Harith Rajagopalan, M.D., Ph.D. was appointed President, effective October 30, 2026. Harith Rajagopalan, M.D., Ph.D. has spoken on 1 investor event across 1 company, most recently for Fractyl Health, Inc. on November 12, 2026. Fractyl Health, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Fractyl Health, Inc. includes Harith Rajagopalan (CEO and Board Member), Lara Smith Weber (CFO), Sarah Toomey (General Counsel) and 3 others.

“In connection with Mr. Caplan’s departure, on October 21, 2026, the Board of Directors of the Company appointed Harith Rajagopalan, M.D., Ph.D., the Company’s Co-Founder, Chief Executive Officer and a member of the Board, to serve as President of the Company, effective as of the Separation Date, in addition to his continuing roles as Chief Executive Officer and as a director of the Company.”
Fractyl Health, Inc. Form 8-K, filed October 22, 2026 · Read the filing

Harith Rajagopalan, M.D., Ph.D. on recent calls

“Nearly 30 million Americans are now on GLP-1 therapy. Approximately 1 million are discontinuing GLP-1s each month. Yet... Those who take GLP-1s, only 1 in 12 Americans remain on them for obesity at the end of three years.”
CEO, Fractyl Health 3Q 2026 Financial Results and Business Update Conference ·

Affiliation history

Company network

Leadership on record at Fractyl Health, Inc.

Recent activity